ESR1 and triple-negative breast carcinoma: Notably, the model’s predictive accuracy was highest for the HER2-enriched and triple negative breast cancer (TNBC, ER- PR- HER2-) subtypes (C-statistics/AUC of 0.878 and 0.870 respectively) (Supplementary Figure S1).